Trial
NCT01437943
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
Novartis
Condition
Kidney Disease
Intervention
Aliskiren
Why stopped
Novartis has have decided to terminate all clinical investigator-initiated research projects involving aliskiren
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-01